Interim AHA Labeling Guidance Proposed By FDA Pending NTP Study Results
This article was originally published in The Rose Sheet
Executive Summary
FDA's draft guidance for labeling of alpha hydroxy acid-containing products is an interim step taken while the agency continues to evaluate AHAs and their impact on increased skin sensitivity to the sun, FDA says in a Dec. 2 1Federal Register notice
You may also be interested in...
FDA Final Guidance On AHAs Clarifies “Sunburn Alert” Labeling
FDA is modifying recommendations for which alpha hydroxy acid-containing cosmetics should carry "Sunburn Alert" labeling to include products that may be applied unintentionally to areas of the body that are exposed to sun, such as those that contain fragrance ingredients, humectants and skin conditioning agents
FDA Final Guidance On AHAs Clarifies “Sunburn Alert” Labeling
FDA is modifying recommendations for which alpha hydroxy acid-containing cosmetics should carry "Sunburn Alert" labeling to include products that may be applied unintentionally to areas of the body that are exposed to sun, such as those that contain fragrance ingredients, humectants and skin conditioning agents
AHA, BHA Products Are Cosmetics Based On Legal Precedent – CTFA
FDA should not address cosmetic compliance issues by reclassifying entire categories of products as drugs, the Cosmetic, Toiletry and Fragrance Association asserts in comments to the agency